VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IRDOpus Genetics, Inc.
$4.00$3.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIRDQuarterly Financials

Opus Genetics, Inc. (IRD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Opus Genetics, Inc. (IRD) quarterly income statement — complete revenue, gross profit & net income history

IRD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue2.16M3.87M3.08M2.88M4.37M4.3M3.87M1.11M1.71M1.69M11.94M3.67M
Revenue Growth %-50.64%-10.16%-20.38%159.17%155.41%154.41%-67.6%-69.73%-2.17%-95.76%--
Cost of Goods Sold13K006.02M07.78M0004.7M00
COGS % of Revenue0.6%--208.95%-180.8%---277.82%--
Gross Profit2.14M3.87M3.08M-3.14M4.37M-3.48M3.87M1.11M1.71M-3.01M11.94M3.67M
Gross Margin %99.4%100%100%-108.95%100%-80.8%100%100%100%-177.82%100%100%
Gross Profit Growth %-50.94%211.19%-20.38%-382.37%155.41%-15.6%-67.6%-69.73%144.49%-107.55%--
Operating Expenses16.51M15.32M11.39M5.77M14.3M34.55M11.88M9.44M9.42M2.42M5.55M9.06M
OpEx % of Revenue765.32%396.33%369.93%200.07%327.21%803.18%307.11%848.92%550.5%143.23%46.49%246.68%
Selling, General & Admin5.93M4.89M4.98M5.77M6.35M7.27M2.89M3.35M4.67M3.25M2.06M4.34M
SG&A % of Revenue274.97%126.52%161.77%200.07%145.22%168.99%74.84%301.62%272.94%192.31%17.22%118.13%
Research & Development10.58M10.43M6.41M6.02M7.95M7.03M8.98M6.09M4.75M3.84M3.49M4.72M
R&D % of Revenue490.36%269.81%208.15%208.95%181.99%163.51%232.27%547.3%277.56%227.14%29.28%128.55%
Other Operating Expenses000-1000K01000K000-1000K00
Operating Income-14.36M-11.45M-8.31M-8.91M-9.93M-38.03M-8.01M-8.33M-7.71M-5.43M6.39M-5.39M
Operating Margin %-665.92%-296.33%-269.93%-309.02%-227.21%-883.98%-207.11%-748.92%-450.5%-321.05%53.51%-146.68%
Operating Income Growth %-44.67%69.88%-3.77%-6.94%-28.81%-600.48%-225.42%-54.54%-25.72%-115.87%240.72%-9.13%
EBITDA-14.35M-11.44M-8.3M-8.89M-9.92M-38.03M-7.53M-8.33M-7.11M-5.43M6.39M-5.39M
EBITDA Margin %-665.32%-295.99%-269.5%-308.54%-226.91%-883.93%-194.62%-748.92%-415.31%-320.88%53.51%-146.65%
EBITDA Growth %-44.73%69.92%-10.26%-6.77%-39.54%-600.82%-217.83%-54.57%-15.92%-115.86%240.78%-9.14%
D&A (Non-Cash Add-back)13K13K13K14K13K2.5K0003K1K1K
EBIT-14.36M-15.13M-17.39M-8.91M-6.82M-10.03M-7.53M-8.33M-7.11M-5.43M6.9M-5.39M
Net Interest Income149K-1.4M-68K-35K-1.37M0500K563K600K0-1.33M0
Interest Income800K00000500K563K600K000
Interest Expense651K1.4M68K35K1.37M000001.33M0
Other Income/Expense-51.17M-5.07M-9.14M1.49M1.74M2.89M483K563K602K632K-811K428K
Pretax Income-65.53M-16.52M-17.45M-7.42M-8.19M-35.13M-7.53M-7.76M-7.11M-4.8M5.58M-4.96M
Pretax Margin %-3038.25%-427.5%-566.87%-257.46%-187.51%-816.71%-194.62%-698.29%-415.31%-283.68%46.71%-135.03%
Income Tax000000000-2K14K0
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0.04%0.25%0%
Net Income-65.53M-16.52M-17.45M-7.42M-8.19M-35.13M-7.53M-7.76M-7.11M-4.79M5.56M-4.96M
Net Margin %-3038.25%-427.5%-566.87%-257.46%-187.51%-816.71%-194.62%-698.29%-415.31%-283.56%46.59%-135.03%
Net Income Growth %-699.79%52.97%-131.92%4.44%-15.31%-632.74%-235.34%-56.52%-22.71%-114.13%222.73%-0.69%
Net Income (Continuing)-65.53M-16.52M-17.45M-7.42M-8.19M-35.13M-7.53M-7.76M-7.11M-4.79M5.56M-4.96M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.75-0.19-0.25-0.12-0.24-1.11-0.29-0.30-0.29-0.220.25-0.24
EPS Growth %-212.5%82.88%13.79%60%17.24%-404.55%-216%-25%-3.57%-113.92%213.64%4%
EPS (Basic)-0.75-0.19-0.25-0.12-0.24-1.11-0.29-0.30-0.29-0.220.26-0.24
Diluted Shares Outstanding868.91M622.22M70.64M63.38M33.88M31.57M26.15M25.83M24.52M22M22.41M20.96M
Basic Shares Outstanding868.91M622.22M70.64M63.38M33.88M31.57M26.15M25.83M24.52M21.52M21.45M20.96M
Dividend Payout Ratio------------